0000950170-24-041790.txt : 20240404
0000950170-24-041790.hdr.sgml : 20240404
20240404160048
ACCESSION NUMBER: 0000950170-24-041790
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dooley Mary Beth
CENTRAL INDEX KEY: 0002015112
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 24823079
MAIL ADDRESS:
STREET 1: 301 BINNEY ST., SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
ownership.xml
4
X0508
4
2024-04-02
0001527599
SYNLOGIC, INC.
SYBX
0002015112
Dooley Mary Beth
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
false
true
false
false
Head of Finance
false
Common Stock
2024-04-02
4
S
false
188
1.73
D
15231
D
Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of four restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021, 2022 and 2023.
/s/ Mary Beth Dooley
2024-04-04